中国医药导报2024,Vol.21Issue(5) :41-44.DOI:10.20047/j.issn1673-7210.2024.05.10

中医药干预类风湿性关节炎Th17/Treg平衡的研究进展

Research progress on traditional Chinese medicine intervention of Th17/Treg balance in rheumatoid arthritis

林治国 兰小雨 陆燕 吴婷婷 王丽 纪伟
中国医药导报2024,Vol.21Issue(5) :41-44.DOI:10.20047/j.issn1673-7210.2024.05.10

中医药干预类风湿性关节炎Th17/Treg平衡的研究进展

Research progress on traditional Chinese medicine intervention of Th17/Treg balance in rheumatoid arthritis

林治国 1兰小雨 2陆燕 2吴婷婷 1王丽 1纪伟2
扫码查看

作者信息

  • 1. 江苏省昆山市中医医院风湿免疫科,江苏昆山 215000
  • 2. 江苏省中医院风湿免疫科,江苏南京 210000
  • 折叠

摘要

类风湿性关节炎(RA)是一种以侵蚀性关节炎症为主要临床表现的自身免疫性疾病,其病因和发病机制尚未完全阐明.研究表明Th17/Treg轴失衡是RA发病的重要机制,纠正Th17/Treg轴失衡对治疗RA具有重要意义.中医药对RA的防治具有独特优势,近年来,一系列实验及临床研究表明中药能够有效纠正Th17/Treg失衡状态,从而抑制RA自身免疫炎症反应.本文总结与分析了近5年来关于中药单体、有效成分和中药复方对RA中Th17/Treg轴的干预研究,有利于更加全面地认识中医药干预RA中Th17/Treg平衡的作用机制,为进一步治疗RA提供参考.

Abstract

Rheumatoid arthritis(RA)is an autoimmune disease characterized by erosive arthritis as the main clinical manifestation,and its etiology and pathogenesis have not been fully elucidated.Studies have shown that the imbalance of Th17/Treg axis is an important mechanism in the development of RA,and correcting this imbalance has significant implications for the treatment of RA.Traditional Chinese medicine has unique advantages in the prevention and treatment of RA.In recent years,a series of experimental and clinical studies have shown that Chinese herbal medicine can effectively correct the imbalance of Th17/Treg axis,thereby inhibiting the autoimmune inflammatory response in RA.This article summarizes and analyzes the intervention studies on the Th 17/Treg axis in RA by Chinese herbal monomers,active ingredients,and herbal formulas in the past five years,which is conducive to a more comprehensive understanding of the mechanism of action of traditional Chinese medicine intervention in balancing Th 17/Treg in RA,and providing reference for further treatment of RA.

关键词

类风湿性关节炎/中医药/Th17/Treg/研究进展

Key words

Rheumatoid arthritis/Traditional Chinese medicine/Th17/Treg/Research progress

引用本文复制引用

基金项目

江苏省中医药局科技项目(ZD201804)

出版年

2024
中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
参考文献量33
段落导航相关论文